LYMPHOSEEK KIT (Technetium Tc-99M Tilmanocept) Patent Expiration, LOE Window & CMS Spending

LYMPHOSEEK KIT (Technetium Tc-99M Tilmanocept) by Cardinal Health 414 Cardinal Health Nuclear Pharmacy Services: FDA Orange Book core substance LOE 2029-01-30, 0 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCardinal Health 414 Cardinal Health Nuclear Pharmacy Services
FDA Application & PathwayN202207 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE Date2029-01-30
Last Listed Patent or Exclusivity Date2029-01-30
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel